To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more

 
 

Paclitaxel default diluent change

The default diluent for paclitaxel is changing from glucose 5% to sodium chloride 0.9% to reflect clinical practice and longer stability data. Diluents are included on eviQ as defaults only and glucose 5% is still a suitable option.

Adult neutropenia, fever and sepsis

New eviQ Education module. This course presents information about the epidemiology, clinical manifestations and management principles of adult fever and neutropenia.

Pegfilgrastim recent PBS changes

Following the 1st August 2018 expanded PBS listing for pegfilgrastim to include primary prophylaxis for patients with >20% risk of FN, eviQ is reviewing all impacted protocols. Further information of protocol updates will follow.
 

Prof. Robyn Ward talks about eviQ

See eviQ's Program Director Professor Robyn Ward talk about how and why eviQ was developed, its purpose and the governance processes that ensure its high quality content.